Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-24

Clinical Trial Update: Dexmedetomidine Pharmacokinetics During Continuous Renal Replacement Therapy (CRRT) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update examining the pharmacokinetics of dexmedetomidine during continuous renal replacement therapy in patients with acute kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Acute Kidney Injury | Phase 2, Phase 3 | Status: UNKNOWN